Glanbia plc
United Kingdom · IE0000669501 · reports in USD · Europe
The answers
From the annual report for the year to Jan 3, 2026. Each line says what it is based on.
- Is it growing?Fair
- Revenue +2.8% in the year to Jan 3, 2026, on the year before.
- Is it a good business?Fair
- It earned 9.5% on its shareholders' equity in the year to Jan 3, 2026.
- Is it safe?Fair
- Equity is 48% of its assets, and operations brought in cash in the year.
- Is the price fair?n/a
- Not answered: no exchange publishes this company's price for free reuse, so there is no P/E here.
The year
Year to Jan 3, 2026, consolidated, in USD.
$3.9B
revenue
6.9%
operating margin
$183M
net profit
Year by year
As filed; an earlier year can differ from its own report when the company restated it.
| Dec 2022 | Dec 2023 | Jan 2025 | Jan 2026 | |
|---|---|---|---|---|
| Revenue | $5.9B | $5.4B | $3.8B | $3.9B |
| Operating profit | $236M | $392M | $235M | $273M |
| Net profit to shareholders | $271M | $344M | $165M | $183M |
| Earnings per share | $0.98 | $1.29 | $0.63 | $0.73 |
| Dividend per share | $0.18 | $0.19 | n/a | n/a |
| Cash from operations | $314M | $428M | $443M | $369M |
| Capital spending | $33M | $42M | $54M | $50M |
| Cash | $468M | $414M | $417M | $491M |
| Total assets | $4.1B | $3.8B | $3.9B | $4.0B |
| Equity | $2.0B | $2.1B | $2.1B | $1.9B |
What they do
In the company's own words, from the annual report.
a leading global nutrition group with geographical presence in regions that include Americas, Europe and Asia Pacific.
Source: the company’s annual financial report in ESEF, via filings.xbrl.org (XBRL International). Listed shares from ESMA’s FIRDS register; ESMA does not endorse this site. Ryufin computed the answers and ratios from the filed figures.